396 related articles for article (PubMed ID: 35734821)
1. Nuclear hormone receptors in demyelinating diseases.
Zorrilla Veloz RI; McKenzie T; Palacios BE; Hu J
J Neuroendocrinol; 2022 Jul; 34(7):e13171. PubMed ID: 35734821
[TBL] [Abstract][Full Text] [Related]
2. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.
Hussain R; Ghoumari AM; Bielecki B; Steibel J; Boehm N; Liere P; Macklin WB; Kumar N; Habert R; Mhaouty-Kodja S; Tronche F; Sitruk-Ware R; Schumacher M; Ghandour MS
Brain; 2013 Jan; 136(Pt 1):132-46. PubMed ID: 23365095
[TBL] [Abstract][Full Text] [Related]
3. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Hirahara Y; Matsuda KI; Yamada H; Saitou A; Morisaki S; Takanami K; Boggs JM; Kawata M
Glia; 2013 Mar; 61(3):420-31. PubMed ID: 23281138
[TBL] [Abstract][Full Text] [Related]
5. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
6. A new model of cuprizone-mediated demyelination/remyelination.
Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
[TBL] [Abstract][Full Text] [Related]
7. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
8. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
9. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
10. Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
Jensen SK; Yong VW
Trends Neurosci; 2016 Jun; 39(6):356-365. PubMed ID: 27113322
[TBL] [Abstract][Full Text] [Related]
11. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
12. Remyelinating strategies in multiple sclerosis.
Luessi F; Kuhlmann T; Zipp F
Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
14. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
15. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.
El-Etr M; Rame M; Boucher C; Ghoumari AM; Kumar N; Liere P; Pianos A; Schumacher M; Sitruk-Ware R
Glia; 2015 Jan; 63(1):104-17. PubMed ID: 25092805
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
Enrich-Bengoa J; Manich G; Dégano IR; Perálvarez-Marín A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499195
[TBL] [Abstract][Full Text] [Related]
17. Laquinimod Supports Remyelination in Non-Supportive Environments.
Nyamoya S; Steinle J; Chrzanowski U; Kaye J; Schmitz C; Beyer C; Kipp M
Cells; 2019 Oct; 8(11):. PubMed ID: 31683658
[TBL] [Abstract][Full Text] [Related]
18. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
